Loading...
Keywords
Last Name
Institution

A multi-omics approach to overcome resistance in infant leukemia by identifying immune-therapy failure mechanisms


Collapse Biography 
Collapse contributor

Collapse Overview 
Collapse abstract
Our goals are to understand how to best target KMT2A-rearranged leukemia in infants with CAR-T cells (to prevent relapse) and how to make the T-cells from these infants into CAR-T cells (to maximize response).
Collapse sponsor award id
CA190407

Collapse Time 
Collapse start date
2020-09-01
Collapse end date
2023-08-31